Constitutive overexpression of TGF-β was shown to induce interstitial cardiac fibrosis and cardiac hypertrophy in transgenic mice [3], whereas targeting TGF-β or its downstream mediators successfully reduced or prevented cardiac fibrosis in various animal models [4,5,6]. This evidence concerns the gene TGFB1 and cardiac hypertrophy.